160 related articles for article (PubMed ID: 37964634)
1. Exploring the DNA methylome of Korean patients with colorectal cancer consolidates the clinical implications of cancer-associated methylation markers.
Lee S; Lee KY; Park JH; Kim DW; Oh HK; Oh ST; Jeon J; Lee D; Joe S; Chu HBK; Kang J; Lee JY; Cho S; Shim H; Kim SC; Lee HS; Kim YJ; Yang JO; Lee J; Kang SB
BMB Rep; 2024 Mar; 57(3):161-166. PubMed ID: 37964634
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the DNA methylation landscape of colorectal cancer in a Korean cohort.
Lim SB; Joe S; Kim HJ; Lee JL; Park IJ; Yoon YS; Kim CW; Kim JH; Kim S; Lee JY; Shim H; Bao Khanh Chu H; Cho S; Kang J; Kim SC; Lee HS; Kim YJ; Kim SY; Yu CS
BMB Rep; 2023 Oct; 56(10):569-574. PubMed ID: 37605616
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive profiling of DNA methylation in Korean patients with colorectal cancer.
Shim H; Jang K; Bang YH; Chu HBK; Kang J; Lee JY; Cho S; Lee HS; Jeon J; Hwang T; Joe S; Lim J; Choi JH; Joo EH; Park K; Moon JH; Han KY; Hong Y; Lee WY; Kim HC; Yun SH; Cho YB; Park YA; Huh JW; Shin JK; Pyo DH; Hong H; Lee HO; Park WY; Yang JO; Kim YJ
BMB Rep; 2024 Feb; 57(2):110-115. PubMed ID: 37605617
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic insights into colorectal cancer: comprehensive genome-wide DNA methylation profiling of 294 patients in Korea.
Joe S; Kim J; Lee JY; Jeon J; Byeon I; Han SW; Ryoo SB; Park KJ; Song SH; Cho S; Shim H; Bao Khanh Chu H; Kang J; Lee HS; Kim D; Kim YJ; Kim TY; Kim SY
BMB Rep; 2023 Oct; 56(10):563-568. PubMed ID: 37574809
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
[TBL] [Abstract][Full Text] [Related]
6. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
7. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
8. Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status.
Kim JH; Rhee YY; Bae JM; Kwon HJ; Cho NY; Kim MJ; Kang GH
Mod Pathol; 2013 Jul; 26(7):1013-22. PubMed ID: 23370766
[TBL] [Abstract][Full Text] [Related]
9. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
[TBL] [Abstract][Full Text] [Related]
10. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer.
Nosho K; Shima K; Irahara N; Kure S; Baba Y; Kirkner GJ; Chen L; Gokhale S; Hazra A; Spiegelman D; Giovannucci EL; Jaenisch R; Fuchs CS; Ogino S
Clin Cancer Res; 2009 Jun; 15(11):3663-71. PubMed ID: 19470733
[TBL] [Abstract][Full Text] [Related]
11. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features.
Ang PW; Loh M; Liem N; Lim PL; Grieu F; Vaithilingam A; Platell C; Yong WP; Iacopetta B; Soong R
BMC Cancer; 2010 May; 10():227. PubMed ID: 20492682
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of CpG island methylation within divergent and unidirectional promoters in colorectal cancer.
Namba S; Sato K; Kojima S; Ueno T; Yamamoto Y; Tanaka Y; Inoue S; Nagae G; Iinuma H; Hazama S; Ishihara S; Aburatani H; Mano H; Kawazu M
Cancer Sci; 2019 Mar; 110(3):1096-1104. PubMed ID: 30637877
[TBL] [Abstract][Full Text] [Related]
14. Toward a comprehensive and systematic methylome signature in colorectal cancers.
Ashktorab H; Rahi H; Wansley D; Varma S; Shokrani B; Lee E; Daremipouran M; Laiyemo A; Goel A; Carethers JM; Brim H
Epigenetics; 2013 Aug; 8(8):807-15. PubMed ID: 23975090
[TBL] [Abstract][Full Text] [Related]
15. The role of the CpG island methylator phenotype on survival outcome in colon cancer.
Kang KJ; Min BH; Ryu KJ; Kim KM; Chang DK; Kim JJ; Rhee JC; Kim YH
Gut Liver; 2015 Mar; 9(2):202-7. PubMed ID: 25167802
[TBL] [Abstract][Full Text] [Related]
16. A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival.
Jia M; Zhang Y; Jansen L; Walter V; Edelmann D; Gündert M; Tagscherer KE; Roth W; Bewerunge-Hudler M; Herpel E; Kloor M; Ulrich A; Burwinkel B; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
Clin Epigenetics; 2019 Jul; 11(1):109. PubMed ID: 31340858
[TBL] [Abstract][Full Text] [Related]
17. IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.
Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS; Ogino S
Neoplasia; 2007 Dec; 9(12):1091-8. PubMed ID: 18084616
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.
Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S
PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263
[TBL] [Abstract][Full Text] [Related]
19. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS
BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983
[TBL] [Abstract][Full Text] [Related]
20. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
